Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers

In this double-blind, cross-over, placebo-controlled, randomized study, possible extraintestinal effects of miglitol, an absorbable alpha-glucosidase inhibitor, were investigated. Sixteen healthy male volunteers underwent two 75 g oral glucose tolerance tests with concomitant administration of migli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of clinical pharmacology 1996-10, Vol.42 (4), p.503-506
Hauptverfasser:	SELS, J. P. J. E, NAUTA, J. J. P, MENHEERE, P. P. C. A, WOLFFENBUTTEL, B. H. R, NIEUWENHUIJZEN KRUSEMAN, A. C
Format:	Artikel
Sprache:	eng
Schlagworte:	1-Deoxynojirimycin - analogs & derivatives Adult Area Under Curve Biological and medical sciences Blood Glucose - metabolism C-Peptide - blood Double-Blind Method Enzyme Inhibitors - adverse effects Enzyme Inhibitors - pharmacokinetics Enzyme Inhibitors - pharmacology General and cellular metabolism. Vitamins Glucosamine - adverse effects Glucosamine - analogs & derivatives Glucosamine - pharmacokinetics Glucosamine - pharmacology Glycoside Hydrolase Inhibitors Humans Imino Pyranoses Insulin - blood Intestine, Small - metabolism Male Medical sciences Original Pharmacology. Drug treatments Placebos
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!